Scandinavian ChemoTech Reports First Quarter 2024 Earnings - Simply Wall St
| CMOTEC-B | SEK 1.11 0.05 4.72% |
About 54% of Scandinavian ChemoTech's investors are presently thinking to get in. The analysis of current outlook of investing in Scandinavian ChemoTech AB suggests that some traders are interested regarding Scandinavian ChemoTech's prospects. The current market sentiment, together with Scandinavian ChemoTech's historical and current headlines, can help investors time the market. In addition, many technical investors use Scandinavian ChemoTech stock news signals to limit their universe of possible portfolio assets.
Scandinavian |
Scandinavian ChemoTech Reports First Quarter 2024 Earnings Simply Wall St
Read at news.google.com
 |
Scandinavian ChemoTech Fundamental Analysis
We analyze Scandinavian ChemoTech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Scandinavian ChemoTech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Scandinavian ChemoTech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
Scandinavian ChemoTech is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
Scandinavian ChemoTech Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Scandinavian ChemoTech stock to make a market-neutral strategy. Peer analysis of Scandinavian ChemoTech could also be used in its relative valuation, which is a method of valuing Scandinavian ChemoTech by comparing valuation metrics with similar companies.
Peers
Scandinavian ChemoTech Related Equities
| ERMA | Enorama Pharma | 4.71 | ||||
| ALZ | Alzinova | 3.90 | ||||
| CANTA | Cantargia | 2.25 | ||||
| VICO | Vicore Pharma | 3.09 | ||||
| XINT | Xintela AB | 4.88 |
Complementary Tools for Scandinavian Stock analysis
When running Scandinavian ChemoTech's price analysis, check to measure Scandinavian ChemoTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scandinavian ChemoTech is operating at the current time. Most of Scandinavian ChemoTech's value examination focuses on studying past and present price action to predict the probability of Scandinavian ChemoTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scandinavian ChemoTech's price. Additionally, you may evaluate how the addition of Scandinavian ChemoTech to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |